Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Congenital Heart Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Medication
1.2.3 Surgical Therapy
1.3 Market by Application
1.3.1 Global Congenital Heart Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and clinics
1.3.3 Diagnostic centres
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Congenital Heart Disease Market Perspective (2018-2033)
2.2 Congenital Heart Disease Growth Trends by Region
2.2.1 Global Congenital Heart Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Congenital Heart Disease Historic Market Size by Region (2018-2023)
2.2.3 Congenital Heart Disease Forecasted Market Size by Region (2024-2033)
2.3 Congenital Heart Disease Market Dynamics
2.3.1 Congenital Heart Disease Industry Trends
2.3.2 Congenital Heart Disease Market Drivers
2.3.3 Congenital Heart Disease Market Challenges
2.3.4 Congenital Heart Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Congenital Heart Disease Players by Revenue
3.1.1 Global Top Congenital Heart Disease Players by Revenue (2018-2023)
3.1.2 Global Congenital Heart Disease Revenue Market Share by Players (2018-2023)
3.2 Global Congenital Heart Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Congenital Heart Disease Revenue
3.4 Global Congenital Heart Disease Market Concentration Ratio
3.4.1 Global Congenital Heart Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Congenital Heart Disease Revenue in 2022
3.5 Congenital Heart Disease Key Players Head office and Area Served
3.6 Key Players Congenital Heart Disease Product Solution and Service
3.7 Date of Enter into Congenital Heart Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Congenital Heart Disease Breakdown Data by Type
4.1 Global Congenital Heart Disease Historic Market Size by Type (2018-2023)
4.2 Global Congenital Heart Disease Forecasted Market Size by Type (2024-2033)
5 Congenital Heart Disease Breakdown Data by Application
5.1 Global Congenital Heart Disease Historic Market Size by Application (2018-2023)
5.2 Global Congenital Heart Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Congenital Heart Disease Market Size (2018-2033)
6.2 North America Congenital Heart Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Congenital Heart Disease Market Size by Country (2018-2023)
6.4 North America Congenital Heart Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Congenital Heart Disease Market Size (2018-2033)
7.2 Europe Congenital Heart Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Congenital Heart Disease Market Size by Country (2018-2023)
7.4 Europe Congenital Heart Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Congenital Heart Disease Market Size (2018-2033)
8.2 Asia-Pacific Congenital Heart Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Congenital Heart Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Congenital Heart Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Congenital Heart Disease Market Size (2018-2033)
9.2 Latin America Congenital Heart Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Congenital Heart Disease Market Size by Country (2018-2023)
9.4 Latin America Congenital Heart Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Congenital Heart Disease Market Size (2018-2033)
10.2 Middle East & Africa Congenital Heart Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Congenital Heart Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Congenital Heart Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Congenital Heart Disease Introduction
11.1.4 Pfizer Revenue in Congenital Heart Disease Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Congenital Heart Disease Introduction
11.2.4 Novartis Revenue in Congenital Heart Disease Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Congenital Heart Disease Introduction
11.3.4 Abbott Laboratories Revenue in Congenital Heart Disease Business (2018-2023)
11.3.5 Abbott Laboratories Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Congenital Heart Disease Introduction
11.4.4 Roche Revenue in Congenital Heart Disease Business (2018-2023)
11.4.5 Roche Recent Development
11.5 GSK
11.5.1 GSK Company Detail
11.5.2 GSK Business Overview
11.5.3 GSK Congenital Heart Disease Introduction
11.5.4 GSK Revenue in Congenital Heart Disease Business (2018-2023)
11.5.5 GSK Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Congenital Heart Disease Introduction
11.6.4 Sanofi Revenue in Congenital Heart Disease Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Congenital Heart Disease Introduction
11.7.4 Johnson & Johnson Revenue in Congenital Heart Disease Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Detail
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Congenital Heart Disease Introduction
11.8.4 Medtronic Revenue in Congenital Heart Disease Business (2018-2023)
11.8.5 Medtronic Recent Development
11.9 BD
11.9.1 BD Company Detail
11.9.2 BD Business Overview
11.9.3 BD Congenital Heart Disease Introduction
11.9.4 BD Revenue in Congenital Heart Disease Business (2018-2023)
11.9.5 BD Recent Development
11.10 Boston Scientific
11.10.1 Boston Scientific Company Detail
11.10.2 Boston Scientific Business Overview
11.10.3 Boston Scientific Congenital Heart Disease Introduction
11.10.4 Boston Scientific Revenue in Congenital Heart Disease Business (2018-2023)
11.10.5 Boston Scientific Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Congenital Heart Disease Introduction
11.11.4 Merck Revenue in Congenital Heart Disease Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Detail
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Congenital Heart Disease Introduction
11.12.4 Eli Lilly Revenue in Congenital Heart Disease Business (2018-2023)
11.12.5 Eli Lilly Recent Development
11.13 Mylan
11.13.1 Mylan Company Detail
11.13.2 Mylan Business Overview
11.13.3 Mylan Congenital Heart Disease Introduction
11.13.4 Mylan Revenue in Congenital Heart Disease Business (2018-2023)
11.13.5 Mylan Recent Development
11.14 Sun Pharmaceutical
11.14.1 Sun Pharmaceutical Company Detail
11.14.2 Sun Pharmaceutical Business Overview
11.14.3 Sun Pharmaceutical Congenital Heart Disease Introduction
11.14.4 Sun Pharmaceutical Revenue in Congenital Heart Disease Business (2018-2023)
11.14.5 Sun Pharmaceutical Recent Development
11.15 AstraZeneca
11.15.1 AstraZeneca Company Detail
11.15.2 AstraZeneca Business Overview
11.15.3 AstraZeneca Congenital Heart Disease Introduction
11.15.4 AstraZeneca Revenue in Congenital Heart Disease Business (2018-2023)
11.15.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Congenital Heart Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Medication
Table 3. Key Players of Surgical Therapy
Table 4. Global Congenital Heart Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Congenital Heart Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Congenital Heart Disease Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Congenital Heart Disease Market Share by Region (2018-2023)
Table 8. Global Congenital Heart Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Congenital Heart Disease Market Share by Region (2024-2033)
Table 10. Congenital Heart Disease Market Trends
Table 11. Congenital Heart Disease Market Drivers
Table 12. Congenital Heart Disease Market Challenges
Table 13. Congenital Heart Disease Market Restraints
Table 14. Global Congenital Heart Disease Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Congenital Heart Disease Market Share by Players (2018-2023)
Table 16. Global Top Congenital Heart Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congenital Heart Disease as of 2022)
Table 17. Ranking of Global Top Congenital Heart Disease Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Congenital Heart Disease Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Congenital Heart Disease Product Solution and Service
Table 21. Date of Enter into Congenital Heart Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Congenital Heart Disease Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Congenital Heart Disease Revenue Market Share by Type (2018-2023)
Table 25. Global Congenital Heart Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Congenital Heart Disease Revenue Market Share by Type (2024-2033)
Table 27. Global Congenital Heart Disease Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Congenital Heart Disease Revenue Market Share by Application (2018-2023)
Table 29. Global Congenital Heart Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Congenital Heart Disease Revenue Market Share by Application (2024-2033)
Table 31. North America Congenital Heart Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Congenital Heart Disease Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Congenital Heart Disease Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Congenital Heart Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Congenital Heart Disease Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Congenital Heart Disease Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Congenital Heart Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Congenital Heart Disease Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Congenital Heart Disease Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Congenital Heart Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Congenital Heart Disease Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Congenital Heart Disease Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Congenital Heart Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Congenital Heart Disease Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Congenital Heart Disease Market Size by Country (2024-2033) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Congenital Heart Disease Product
Table 49. Pfizer Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Congenital Heart Disease Product
Table 54. Novartis Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Abbott Laboratories Company Detail
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Congenital Heart Disease Product
Table 59. Abbott Laboratories Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Congenital Heart Disease Product
Table 64. Roche Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 65. Roche Recent Development
Table 66. GSK Company Detail
Table 67. GSK Business Overview
Table 68. GSK Congenital Heart Disease Product
Table 69. GSK Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Sanofi Company Detail
Table 72. Sanofi Business Overview
Table 73. Sanofi Congenital Heart Disease Product
Table 74. Sanofi Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Johnson & Johnson Company Detail
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Congenital Heart Disease Product
Table 79. Johnson & Johnson Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Medtronic Company Detail
Table 82. Medtronic Business Overview
Table 83. Medtronic Congenital Heart Disease Product
Table 84. Medtronic Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 85. Medtronic Recent Development
Table 86. BD Company Detail
Table 87. BD Business Overview
Table 88. BD Congenital Heart Disease Product
Table 89. BD Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 90. BD Recent Development
Table 91. Boston Scientific Company Detail
Table 92. Boston Scientific Business Overview
Table 93. Boston Scientific Congenital Heart Disease Product
Table 94. Boston Scientific Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 95. Boston Scientific Recent Development
Table 96. Merck Company Detail
Table 97. Merck Business Overview
Table 98. Merck Congenital Heart Disease Product
Table 99. Merck Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Eli Lilly Company Detail
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly Congenital Heart Disease Product
Table 104. Eli Lilly Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 105. Eli Lilly Recent Development
Table 106. Mylan Company Detail
Table 107. Mylan Business Overview
Table 108. Mylan Congenital Heart Disease Product
Table 109. Mylan Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 110. Mylan Recent Development
Table 111. Sun Pharmaceutical Company Detail
Table 112. Sun Pharmaceutical Business Overview
Table 113. Sun Pharmaceutical Congenital Heart Disease Product
Table 114. Sun Pharmaceutical Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 115. Sun Pharmaceutical Recent Development
Table 116. AstraZeneca Company Detail
Table 117. AstraZeneca Business Overview
Table 118. AstraZeneca Congenital Heart Disease Product
Table 119. AstraZeneca Revenue in Congenital Heart Disease Business (2018-2023) & (US$ Million)
Table 120. AstraZeneca Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Congenital Heart Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Congenital Heart Disease Market Share by Type: 2022 VS 2033
Figure 3. Medication Features
Figure 4. Surgical Therapy Features
Figure 5. Global Congenital Heart Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Congenital Heart Disease Market Share by Application: 2022 VS 2033
Figure 7. Hospitals and clinics Case Studies
Figure 8. Diagnostic centres Case Studies
Figure 9. Congenital Heart Disease Report Years Considered
Figure 10. Global Congenital Heart Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Congenital Heart Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Congenital Heart Disease Market Share by Region: 2022 VS 2033
Figure 13. Global Congenital Heart Disease Market Share by Players in 2022
Figure 14. Global Top Congenital Heart Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congenital Heart Disease as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Congenital Heart Disease Revenue in 2022
Figure 16. North America Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Congenital Heart Disease Market Share by Country (2018-2033)
Figure 18. United States Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Congenital Heart Disease Market Share by Country (2018-2033)
Figure 22. Germany Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Congenital Heart Disease Market Share by Region (2018-2033)
Figure 30. China Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Congenital Heart Disease Market Share by Country (2018-2033)
Figure 38. Mexico Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Congenital Heart Disease Market Share by Country (2018-2033)
Figure 42. Turkey Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Congenital Heart Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 45. Novartis Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 46. Abbott Laboratories Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 47. Roche Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 48. GSK Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 49. Sanofi Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 51. Medtronic Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 52. BD Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 53. Boston Scientific Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 56. Mylan Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 57. Sun Pharmaceutical Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 58. AstraZeneca Revenue Growth Rate in Congenital Heart Disease Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed